Cherry Tree Cancer Center
Hanover, Pennsylvania, United States
Cancer treatment center in Hanover, Pennsylvania
773 Cherry Tree Ct, Hanover, PA 17331
About Cherry Tree Cancer Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Cherry Tree Cancer Center
During the past decade, Cherry Tree Cancer Center conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 49 clinical trials were completed, i.e. on
average, 106.5% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 30 clinical trials were completed. i.e. 250%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes
1999-03-01
2012-12-01
Completed
5,351
Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
2000-02-01
2019-11-01
Completed
2,130
Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
2001-05-01
2011-02-01
Completed
1,598
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
2002-05-01
2014-06-01
Completed
3,871
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
2003-01-01
2016-05-01
Completed
3,104
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer
2004-01-01
2009-04-01
Completed
134
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-12-17
2025-12-01
Active, not recruiting
3,066
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Cherry Tree Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 40 trials, followed by "SWOG Cancer Research Network" with 17 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 13 trials sponsored, "Radiation Therapy Oncology Group" with 12 trials sponsored and "ECOG-ACRIN Cancer Research Group"
with 12 trials sponsored. Other sponsors include 7 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Cherry Tree Cancer Center"
#1 collaborator was "National Cancer Institute (NCI)" with 60 trials as a collaborator, "NRG Oncology" with 23 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Radiation Therapy Oncology Group" with 2 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were
collaborators in the rest 13 trials.
Clinical Trials Conditions at Cherry Tree Cancer Center
According to Clinical.Site data, the most researched conditions in "Cherry Tree Cancer Center" are
"Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Lung Cancer AJCC v8" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Stage IVA Lung Cancer AJCC v8" (6 trials) and "Stage IVB Lung Cancer AJCC v8" (6 trials). Many other conditions were trialed in "Cherry Tree Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at Cherry Tree Cancer Center
Most popular intervention types in "Cherry Tree Cancer Center" are "Drug" (81 trials), "Other" (67 trials), "Biological" (42 trials), "Procedure" (26 trials) and "Radiation" (20 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (36 trials), "Quality-of-Life Assessment" (25 trials), "Questionnaire Administration" (15 trials), "Paclitaxel" (14 trials) and "Biospecimen Collection" (13 trials). Other intervention names were less common.
Clinical Trials Genders at Cherry Tree Cancer Center
The vast majority of trials in "Cherry Tree Cancer Center" are
78 trials for "All" genders, 17 trials for "Female" genders and 5 trials for "Male" genders.
Clinical Trials Status at Cherry Tree Cancer Center
Currently, there are NaN active trials in "Cherry Tree Cancer Center".
undefined are not yet recruiting,
16 are recruiting,
53 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 21 completed trials in Cherry Tree Cancer Center,
2 suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Cherry Tree Cancer Center, 1 "Phase 1"
clinical trials were conducted, 42 "Phase 2" clinical
trials and 63 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".